ZEPOSIA

Identification of Zeposia

No description

Google image searchProduct monograph

Active ingredient

ozanimod (ozanimod hydrochloride), 0.92 MG

DIN: 02505991

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 03-SEP-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AE — Sphingosine-1-phosphate (S1P) receptor modulators (ATC, ATC/DDD)
• L04AE02 — OZANIMOD (ATC/DDD)

External Links for Zeposia

Search on Google

• Zeposia side effects
• Zeposia dosage
• ozanimod side effects
• ozanimod dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find zeposia photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.